Picture of Aytu Biopharma logo

AYTU — Aytu Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Brief: Aytu Biopharma Inc - Quarterly Net Revenue Increased 53% Year-Over-Year To $23.1 Million

Feb 14 (Reuters) - Aytu Biopharma Inc  AYTU.O :
    * AYTU BIOPHARMA INC - QUARTERLY NET REVENUE INCREASED 53% YEAR-OVER-YEAR TO
$23.1
MILLION
    * AYTU BIOPHARMA INC - NET LOSS FOR Q2 OF FISCAL YEAR 2022 WAS $11.5
MILLION, OR
$0.44 PER SHARE

Source: [https://bit.ly/36iULrf]
Further company coverage:  AYTU.O

Recent news on Aytu Biopharma

See all news